Presentations & Press.
Video presentations and interviews
- Investor Meet Company / Half Year Results, March 2025
- Investor Meet Company / Annual General Meeting, December 2025
- Investor Meet Company / Full Year Results, October 2025
- Proactive Investors / One2One Investor Forum, June 2025
- Investor Meet Company / Half Year Results, March 2025
- Investor Meet Company / Annual General Meeting, December 2024
- LSX Investival Showcase / Sareum Holdings, November 2024
- Edison TV / Sareum Holdings – Executive Interview, November 2024
- Investor Meet Company / Full Year Results, October 2024
- Investor Meet Company / Annual General Meeting, December 2023
- Investor Meet Company / Full Year Results, October 2023
- Investor Meet Company / SDC-1801 CTA Submission, August 2022
- Edison Open House Global Healthcare, February 2022
- “Next Generation TYK2/JAK1 Immunotherapeutics for Autoimmune Diseases, Cancer (and Covid-19)” LSX World Congress, February 2021
- “Sareum Holdings focused on striking a deal for its immunotherapies” Proactive Investors, August 2020
- “Sareum Holdings raises over a £1mln to advance preclinical work on its TYK2/JAK1 drugs” Proactive Investors, June 2020
- “Sareum’s Tim Mitchell looks ahead to critical Phase II data from flagship Chk1 inhibitor” Proactive Investors, March 2019
- “Sareum Holdings plc heartened by Sierra Oncology Progress” Proactive Investors, March 2018
Slide presentations
Company Presentation (March 2026)
- Investor Meet Company / Half Year Results, March 2026
- Investor Meet Company / Full Year Results, October 2025
- Investor Meet Company / Half Year Results, March 2025
- Investor Meet Company / Full Year Results, October 2024
- Investor Meet Company / CTA Submission, August 2022
- BioTrinity, April 2022
- Investor Meet Company / Half Year Results, February 2022
- Investor Meet Company / Full Year Results, October 2021
In the news
- Business Weekly “Sareum rallies after strong trial data and re-secures key cancer drug licence” Link to online article 23 October 2025
- BNN Breaking “Sareum Holdings PLC’s SDC-1801: A New Era in Psoriasis Treatment” Link to online article 15 February 2024
- Business Weekly “Sareum says so long to SAD and hi to happy as trials hurdle is cleared” Link to online article 15 February 2024
- Business Weekly “Sareum shares soar as it starts to cash in on cancer programme” Link to online article 2 January 2024
- Business Weekly “Sareum making encouraging progress with lead asset” Link to online article 9 November 2023
- Business Weekly “Sareum oozing confidence for upcoming trials” Link to online article 12 October 2023
- Business Weekly “Sareum negotiates growth capital worth £6.6M” Link to online article 10 August 2023
- Business Weekly “Sareum trial of SDC-1801 gets underway in Australia” Link to online article 16 June 2023
- Business Weekly “Just wizard in Oz as Sareum heads up Down Under” Link to online article 5 March 2023
- Business Weekly “Sareum Chief upbeat about future cancer prospects” Link to online article 24 October 2022
- Business Weekly “Hat-trick of successes for Sareum Holdings” Link to online article 13 August 2021
- Business Weekly “Sareum Holdings Plc buoyed by white knight’s £900k investment” Link to online article 3 June 2021
- Cambridge Independent “Sareum welcomes revised deal between Sierra and CPF on checkpoint inhibitor” Link to online article 17 November 2020
- Business Weekly “US patent breakthrough for Sareum” Link to online article 8 October 2020
- Cambridge Independent “Sareum raises £1m to advance preclinical studies and targets Covid-19 cytokine storm” Link to online article 10 June 2020
- Business Weekly “Sareum buoyed by China pharma licensing deal” Link to online article 26 March 2020
- Cambridge News “Sareum turns a profit after spectacular six months” Link to online article 20 February 2017
- Business Weekly “Sareum posts maiden profit” Link to online article 20 February 2017
- Cambridge News “Why Sareum is in the money again” Link to online article 11 January 2017
- Cambridge Business “Little Big Firm” p85-87, December 2016 Download Article PDF
- Cambridge News “CEO ‘delighted’ with progress at cancer drug firm Sareum” Link to online article 2 November 2016
- Business Weekly “Japan and Singapore patents for Sareum Technology”. 20 October 2016
- Cambridge News “Celebrate Cambridge: high time for life sciences” Link to online article 28 September 2016
- City AM “Cambridge biotech firm sees shares jump over 100 per cent on US pharma deal” Link to online article 27 September 2016
- Cambridge News “Share price leaps 150% for Cambridge cancer company”. 27 September 2016
- Genetic Engineering & Biotechnology News “ProNAi Licenses Checkpoint Kinase 1 Inhibitor…” Link to online article 27 September 2016
- Business Weekly “US deal hands Sareum share of potential $328M windfall” Link to online article 27 September 2016
- Business Weekly “China and Hong Kong patent boost for Sareum” Link to online article 8 August 2016
- Cambridge News “Movers and shakers: new chairman for Sareum…”. 24 May 2016
- Cambridge News “Cambridge cancer drug company sees share price zoom”. 5 April 2016
- Cambridge News “Sareum helps develop ‘chemotherapy-booster’ for patients with lung and pancreatic cancer”. 27 July 2015
- Cambridge News “Sareum lands £140K to develop molecule that could treat leukaemia”. 23 June 2015
- Cambridge News, “Sareum Signs China Deal”. 3 December 2013
- Cambridge News, “High Hopes for New Sareum Cancer Drug”. 16 August 2011
- Cambridge News, “Star Status for Sareum”. 6 July 2011
- Interactive Investor, “AIM Winners and Losers (01/01 – 30/06/11)”. Link to online article 5 July 2011
- Cambridge News, “Tenfold Growth in Two Months”. Download PDF 24 May 2011